This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Genkore Co. Ltd.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Jeong Mi Lee: Innovator in Genome Editing
Introduction
Jeong Mi Lee is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of genome editing, particularly through his innovative work utilizing the CRISPR/Cpf1 system. His research focuses on enhancing the efficiency and accuracy of genetic modifications in eukaryotic cells.
Latest Patents
Jeong Mi Lee holds a patent for a composition for genome editing using the CRISPR/Cpf1 system. This invention relates to a composition that includes a CRISPR RNA (crRNA) with a guide sequence capable of hybridizing with a target nucleotide sequence. The composition also features a uridine repeat sequence connected to the 3'-end of the guide sequence, along with a Cpf1 protein or a DNA encoding the same. This innovative approach aims to increase indel efficiency and reduce off-target activity in genome editing, facilitating the construction of genetically modified organisms.
Career Highlights
Jeong Mi Lee is associated with Genkore Co. Ltd., where he continues to advance his research in genome editing technologies. His work has the potential to revolutionize the field of genetic engineering, making it easier to create genetically modified cells, animals, or plants with desired genetic traits.
Collaborations
Jeong Mi Lee collaborates with notable colleagues, including Yong Sam Kim and Jeong Heon Ko. Their combined expertise contributes to the ongoing advancements in genome editing and related technologies.
Conclusion
Jeong Mi Lee's contributions to genome editing through his innovative patent demonstrate his commitment to advancing genetic research. His work not only enhances the efficiency of genetic modifications but also paves the way for future developments in the field.